Ixiaro
Japanese Encephalitis Vaccine, Inactivated, Adsorbed · Injection, Suspension · Intramuscular
No FDA structured label text is available for Ixiaro. The NDC listings below come from the FDA National Drug Code directory.
Active ingredients
Ixiaro NDC products (2)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 42515-002 | Japanese Encephalitis Virus Strain Sa 14-14-2 Antigen (formaldehyde Inactivated) 6 [arb'U]/.5mL Injection, Suspension | Valneva Scotland Ltd. | BLA |
| 62195-051 | Japanese Encephalitis Virus Strain Sa 14-14-2 Antigen (formaldehyde Inactivated) 6 ug/.5mL Injection, Suspension | Vetter Pharma Fertigung GmbH & Co. KG | BLA |
Frequently asked questions
Who makes Ixiaro?
Ixiaro is listed by 2 labelers in the FDA NDC directory, including Valneva Scotland Ltd., Vetter Pharma Fertigung GmbH & Co. KG.